NCT03566147View on ClinicalTrials.gov

Treatment of RP and LCA by Primary RPE Transplantation

EARLY_PHASE1UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

December 31, 2019

Study Completion Date

March 31, 2020

Conditions
Leber Congenital Amaurosis, Retinitis Pigmentosa
Interventions
BIOLOGICAL

Human primary Retinal Pigment Epithelial (HuRPE) cells

HuRPE will be transplanted by a board-certified vitreoretinal surgeon, which will be administered into the subretinal space of experimental eye through a standard surgical approach.

Trial Locations (1)

Unknown

RECRUITING

Beijing Tongren Hospital, Beijing

Sponsors
All Listed Sponsors
collaborator

Beijing Tongren Hospital

OTHER

lead

Eyecure Therapeutics Inc.

INDUSTRY